In addition, TBX2 was shown to promote cisplatin resistance in endometrial carcinoma by inhibiting ferroptosis, a form of regulated cell death, and accelerating tumour growth in cisplatin-treated mice [54,57]. Here, TBX2 is linked to neoplasm.